Moneycontrol's Shraddha Sharma does a 3-Point Analysis of the company's Q1 numbers.
Moneycontrol News
@moneycontrolcom
Solara Active Pharma Sciences, the active pharmaceutical ingredient entity of Strides and Sequent, posted a strong operating profit for the June quarter.
Moneycontrol's Shraddha Sharma does a 3-Point Analysis of the company's Q1 numbers and gives a verdict on whether you should buy the stock or not.Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.First Published on Sep 4, 2019 07:08 pm
